81816-69-5 Usage
Chemical structure
The compound contains a piperazine group and a chromene ring structure.
Potential drug candidate
It has pharmacological activities and has been studied for its potential use in the treatment of various medical conditions.
Preclinical studies
The compound has shown some promising results in preclinical studies.
Further investigation
It is being further investigated for its therapeutic potential.
Unique chemical structure
Its unique chemical structure makes it a valuable tool in the study of pharmacology and medicinal chemistry.
Molecular weight
355.4 g/mol
Appearance
It is a solid, white to off-white crystalline powder.
Solubility
It is soluble in organic solvents such as methanol, ethanol, and dimethyl sulfoxide (DMSO).
Stability
It is stable under normal temperature and pressure conditions.
Safety
It should be handled with care and proper safety measures should be taken to avoid exposure.
Applications
It has potential applications in the pharmaceutical industry for the development of new drugs for the treatment of various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 81816-69-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,8,1 and 6 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 81816-69:
(7*8)+(6*1)+(5*8)+(4*1)+(3*6)+(2*6)+(1*9)=145
145 % 10 = 5
So 81816-69-5 is a valid CAS Registry Number.
81816-69-5Relevant articles and documents
Phenoxyalkylamines in Semi-rigid Conformation: Synthesis & Pharmacological Activity of N1-(4'-Chromanyl)-N4-arylpiperazines & N1-(2'-Chromanylmethyl)-N4-arylpiperazines
Pratap, Ram,Gupta, R. C.,Anand, Nitya
, p. 1063 - 1067 (2007/10/02)
Synthesis and pharmacological activity of N1-(4'-chromanyl)-N4-arylpiperazines and N1-(chromanylmethyl)-N4-arylpiperazines, cyclic congeners of N1-aryloxyalkyl-N4-arylpiperazines, are reported.None of the compounds of this series shows any significant pharmacological activity.